Financial institutions know the drill by now: They’ve built pilots, launched proofs of concept, dabbled with copilots and chat-based automation—but scaling GenAI into mission-critical workflows remains a stubborn challenge. Between governance hurdles, security concerns, data fragmentation, and the ever-present risk of regulatory blowback, banks and insurers have treated production GenAI like a high-stakes tightrope walk. Read More
